Harvard Bioscience (HBIO) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.67 +0.81%
Revenue Growth %: +6.1%
Financial Fact:
Other, net: -64K
Today's EPS Names:
FUSE, INM, TRI, More
Revenue Growth %: +6.1%
Financial Fact:
Other, net: -64K
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.07, $0.02 better than the analyst estimate of $0.05. Revenue for the quarter came in at $31.5 million versus the consensus estimate of $30.66 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Comscore (SCOR) Misses Q3 EPS by 446c
- Ferroglobe (GSM) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
